Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management At the ESCMID Global 2026, Bruker Corporation unveiled a wide-ranging set of portfolio enhancements spanning microbial identification,…
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 At the ESCMID Global 2026, the Microbiology & Infection Diagnostics division of Bruker Corporation unveiled a major advancement in…
LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar® LEO Pharma A/S has announced a significant regulatory milestone with the approval of Enstilar by China’s National…
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.…
WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug–Device Combination Product Development and Manufacturing WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced…
Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building Ferring Pharmaceuticals and Gallup today announced the Ferring Global Fertility Monitor, a global study on the…
Invivoscribe Announces the PrepQuant™ System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced…
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results CareDx, Inc.,The Transplant Company™, a leading precision medicine company…
Glaukos Receives Permanent J-code for Epioxa™ Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced…
Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant…
AccurKardia Announces Multi-Year Agreement with Specialized Medical to Power its State-of-the-Art Cardiac Monitoring Operations AccurKardia, an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced…
Nucleai and Sirona Dx Partner to Deliver an Integrated Spatial Proteomics Solution for Pharma Drug Development Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO,…